✦ LIBER ✦

Combination Chemotherapy of BCNU and Didox Acts Synergystically in 9L Glioma Cells

✍ Scribed by Zsuzsanna Horvath; Wolfgang Bauer; Thomas Hoechtl; Philipp Saiko; Monika Fritzer-Szekeres; Tarik Tihan; Thomas Szekeres

Publisher: John Wiley and Sons
Year: 2005
Weight: 8 KB
Volume: 36
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200512230

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergistic cytotoxicity of the ribonucl

Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells

✍ Zsuzsanna Horvath; Thomas Höchtl; Wolfgang Bauer; Monika Fritzer-Szekeres; Howar 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 229 KB

Biodisposition and metabolism of [18F]fl

Biodisposition and metabolism of [18F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats

✍ Aditya Bansal; Wang Shuyan; Toshiko Hara; Robert A. Harris; Timothy R. DeGrado 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 238 KB

Comparison of the CCNU and BCNU modifica

Comparison of the CCNU and BCNU modification of the in vitro radiation response in 9l brain tumor cells of rats

✍ Dennis F Deen; Mary E Williams; Kenneth T Wheeler 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Selective and nonselective toxicity of T

Selective and nonselective toxicity of TRAIL/Apo2L combined with chemotherapy in human bone tumour cells vs. normal human cells

✍ Frans Van Valen; Simone Fulda; Karl-Ludwig Schäfer; Borna Truckenbrod; Marc Hotf 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 750 KB

## Abstract Although TRAIL/Apo2L preferably induces apoptosis in tumour cells without toxicity in normal cells, many tumour cell types display TRAIL/Apo2L resistance. Whether TRAIL/Apo2L in combination with chemotherapy may overcome TRAIL/Apo2L resistance while maintaining tumour selectivity remain